Risk of breast cancer recurring persists after end of hormone therapy

10 Nov 2017


According to a study, published in the New England Journal of Medicine, women successfully treated for breast cancer with hormone therapy still have an increased risk of it returning, even 15 years after hormone therapy ended.

Newsweek

 


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story